Bioness Medical Announces 510(k) Clearance for PoNS® (Portable Neuromodulation Stimulator) to Manage Patients Recovering from Stroke
First non-invasive, orally applied neuromodulation device FDA-cleared for stroke rehabilitation, expanding access for the more than 7 million Americans living with stroke-related gait disability Clearance expands PoNS indication beyond existing Multiple Sclerosis approval VALENCIA,...
First non-invasive, orally applied neuromodulation device FDA-cleared for stroke rehabilitation, expanding access for the more than 7 million Americans living with stroke-related gait disability Clearance expands PoNS indication beyond existing Multiple Sclerosis approval VALENCIA,...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.